{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:35:42Z","timestamp":1761708942819},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC 101-2314-B-182A-103-MY3"],"award-info":[{"award-number":["NSC 101-2314-B-182A-103-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejphar.2014.01.049","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T06:15:14Z","timestamp":1391321714000},"page":"124-132","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A salicylate-based small molecule HS-Cm exhibits immunomodulatory effects and inhibits dipeptidyl peptidase-IV activity in human T cells"],"prefix":"10.1016","volume":"726","author":[{"given":"Jun-Ting","family":"Liou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsu-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Lin","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Jun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenn-Haung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.01.049_bib1","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.4049\/jimmunol.173.9.5721","article-title":"A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription","volume":"173","author":"Aceves","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","volume":"101","author":"Awtry","year":"2000","journal-title":"Aspir. Circ."},{"key":"10.1016\/j.ejphar.2014.01.049_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0735-1097(98)00410-0","article-title":"Immune system activation follows inflammation in unstable angina: pathogenetic implications","volume":"32","author":"Caligiuri","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib5","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1182\/blood-2002-12-3893","article-title":"Cell surface peptidase CD26\/DPPIV mediates G-CSF mobilization of mouse progenitor cells","volume":"101","author":"Christopherson","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2014.01.049_bib6","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic aspects of chronic obstructive pulmonary disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.01.049_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2014.01.049_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","article-title":"Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial","volume":"159","author":"Goldfine","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2014.01.049_bib9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/CIRCULATIONAHA.106.656751","article-title":"Immunosuppression in atherosclerosis: mobilizing the opposition within","volume":"114","author":"Goronzy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.01.049_bib10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.01.049_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bjp.0706000","article-title":"Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell","volume":"143","author":"Ho","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","article-title":"Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors","volume":"163","author":"Iniguez","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib14","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1194\/jlr.M800082-JLR200","article-title":"Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin","volume":"49","author":"Jaichander","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2014.01.049_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbapap.2005.08.017","article-title":"MAPK signalling pathways as molecular targets for anti-inflammatory therapy\u2014from molecular mechanisms to therapeutic benefits","volume":"1754","author":"Kaminska","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2014.01.049_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2011.11.030","article-title":"Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-alpha dependent NFkappaB activity: implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis","volume":"48","author":"Kim","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.01.049_bib17","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI61758","article-title":"Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis","volume":"122","author":"Koltsova","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2014.01.049_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2014.01.049_bib19","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.4049\/jimmunol.166.11.6914","article-title":"Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas\/Fas ligand interaction","volume":"166","author":"Lai","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2008.04.056","article-title":"Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells","volume":"589","author":"Liou","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10875-011-9576-9","article-title":"A benzamide-linked small molecule HS-Cf inhibits TNF-alpha-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics","volume":"31","author":"Liu","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10557-009-6210-7","article-title":"Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice","volume":"24","author":"Liu","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2014.01.049_bib23","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.4049\/jimmunol.0804336","article-title":"A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals","volume":"183","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/CS20110234","article-title":"Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study","volume":"122","author":"Meijer","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2014.01.049_bib25","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jacc.2005.03.040","article-title":"Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes","volume":"45","author":"Methe","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coph.2011.09.013","article-title":"Emerging immunological targets in inflammatory bowel disease","volume":"11","author":"Monteleone","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.01.049_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2011.03.025","article-title":"The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease","volume":"128","author":"Pamukcu","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2014.01.049_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrendo.2010.130","article-title":"Diabetes: treatment of diabetes mellitus: new tricks by an old player","volume":"6","author":"Pedersen","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib31","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1242\/jcs.02470","article-title":"MAP kinase pathways","volume":"118","author":"Qi","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2014.01.049_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrendo.2012.114","article-title":"Adaptive immunity in obesity and insulin resistance","volume":"8","author":"Sell","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib33","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2014.01.049_bib34","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2014.01.049_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2014.01.049_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2014.01.049_bib37","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2014.01.049_bib38","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.cca.2012.04.031","article-title":"Lymphocytes in atherosclerosis","volume":"413","author":"Wigren","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2014.01.049_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/B:CARD.0000033638.37830.f7","article-title":"Carvedilol differentially regulates cytokine production from activated human peripheral blood mononuclear cells","volume":"18","author":"Yang","year":"2004","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2014.01.049_bib40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0008-6363(03)00459-0","article-title":"Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity","volume":"59","author":"Yang","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.01.049_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tips.2009.08.003","article-title":"Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?","volume":"30","author":"Yazbeck","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.01.049_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.01.049_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2012.09.012","article-title":"An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease","volume":"226","author":"Zhong","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T02:02:45Z","timestamp":1688954565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":43,"alternative-id":["S001429991400079X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A salicylate-based small molecule HS-Cm exhibits immunomodulatory effects and inhibits dipeptidyl peptidase-IV activity in human T cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}